LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

Search

NeoGenomics Inc

Uždarymo kaina

7.41 4.07

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

7.27

Max

7.42

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-11M

-26M

Pardavimai

-4M

168M

Pelnas, tenkantis vienai akcijai

-0.204

Pelno marža

-15.427

Darbuotojai

2,200

EBITDA

-10M

-6.3M

Rekomendacijos

By TipRanks

Rekomendacijos

Pirkti

12 mėnesių prognozė

+84.99% upside

Dividendai

By Dow Jones

Kitas uždarbis

2025-07-28

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-360M

923M

Ankstesnė atidarymo kaina

3.34

Ankstesnė uždarymo kaina

7.41

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Very Strong Bearish Evidence

NeoGenomics Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-06-04 14:53; UTC

Pagrindinės rinkos jėgos

BitFuFu Shares Climb on Surge in Bitcoin Production

2025-06-04 14:40; UTC

Pagrindinės rinkos jėgos

K Wave Media Shares Triple on Bitcoin Treasury Stock Sale

2025-05-30 08:17; UTC

Svarbiausios naujienos

Global Markets Mixed Amid Tariff Uncertainty; PCE Inflation Data Eyed

2025-06-06 14:28; UTC

Rinkos pokalbiai

Bitcoin Rises After Above-Forecast U.S. Jobs Data -- Market Talk

2025-06-04 21:26; UTC

Įsigijimai, susijungimai, perėmimai

New MicroStrategy Preferred, a Bitcoin Play, Should Yield 10% or More -- Barrons.com

2025-06-04 11:24; UTC

Rinkos pokalbiai

Market Talk Roundup: Latest on U.S. Politics

2025-06-04 11:24; UTC

Rinkos pokalbiai

Bitcoin ETFs See Outflows -- Market Talk

2025-06-04 09:58; UTC

Rinkos pokalbiai

Bitcoin Eases but Remains Attractive Amid Muted Volatility -- Market Talk

2025-06-04 09:58; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2025-06-03 10:28; UTC

Rinkos pokalbiai

Bitcoin Rises, Recovering After Recent Falls -- Market Talk

2025-06-02 11:33; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2025-06-02 11:33; UTC

Rinkos pokalbiai

Bitcoin Falls as Trade Tensions Cause Risk Aversion -- Market Talk

2025-05-30 16:20; UTC

Rinkos pokalbiai

Tech, Media & Telecom Roundup: Market Talk

2025-05-30 13:43; UTC

Rinkos pokalbiai

Trump's Immigration Clampdown a Possible Headwind to Digital Assets -- Market Talk

2025-05-30 13:43; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2025-05-30 07:18; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2025-05-30 07:18; UTC

Rinkos pokalbiai

Bitcoin Falls on Renewed Tariff Concerns -- Market Talk

2025-05-29 07:00; UTC

Rinkos pokalbiai
Uždarbis

Bitcoin Rises After Upbeat Nvidia Earnings, Tariff Ruling -- Market Talk

2025-05-28 08:21; UTC

Rinkos pokalbiai

Bitcoin Falls Ahead of Nvidia Earnings, Fed Minutes -- Market Talk

2025-05-27 20:21; UTC

Svarbiausios naujienos

Trump's Media Company to Raise $2.5 Billion to Buy Bitcoin -- 2nd Update

2025-05-27 15:44; UTC

Svarbiausios naujienos

Trump's Media Company to Raise $2.5 Billion to Buy Bitcoin -- Update

2025-05-27 15:36; UTC

Svarbiausios naujienos

Trump's Media Company to Raise $2.5 Billion to Buy Bitcoin -- Update

2025-05-27 14:44; UTC

Uždarbis
Įsigijimai, susijungimai, perėmimai

DJT Stock Falls. The Truth Social Parent Is Raising $2.5 Billion to Buy Bitcoin. -- Barrons.com

2025-05-27 08:49; UTC

Rinkos pokalbiai

Bitcoin Falls as Trade Uncertainty Dampens Risk Appetite -- Market Talk

2025-05-26 09:57; UTC

Rinkos pokalbiai

Bitcoin Rises as U.S. Delay of Big EU Tariffs Supports Risk Appetite -- Market Talk

2025-05-23 18:52; UTC

Įsigijimai, susijungimai, perėmimai

DDC Enterprise Issues 254,333 Class A Ordinary Shrs in Exchange for 21 BTC, Valued at About $2.28M in Current Market Price

2025-05-23 12:51; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2025-05-23 12:51; UTC

Rinkos pokalbiai

Bitcoin Falls as Trump's EU Tariff Threat Dents Risk Appetite -- Market Talk

2025-05-23 07:31; UTC

Rinkos pokalbiai

Bitcoin Eases Slightly After Reaching Fresh Record High -- Market Talk

2025-05-23 03:16; UTC

Svarbiausios naujienos

Big Banks Explore Venturing Into Crypto World Together With Joint Stablecoin -- WSJ

Akcijų palyginimas

Kainos pokytis

NeoGenomics Inc Prognozė

Kainos tikslas

By TipRanks

84.99% į viršų

12 mėnesių prognozė

Vidutinis 13.19 USD  84.99%

Aukščiausias 26 USD

Žemiausias 8.5 USD

Remiantis 12 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines NeoGenomics Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

12 ratings

7

Pirkti

5

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

7.7 / 10.27Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Very Strong Bearish Evidence

Vidutinės trukmės periodas

Bearish Evidence

Ilgalaikis periodas

Bearish Evidence

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę NeoGenomics Inc

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.